Skip to content

Diclofenac

Published: July 26, 2026Updated: August 26, 2026

Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain, reduce inflammation, and lower fever. It is commonly prescribed for various conditions including osteoarthritis, rheumatoid arthritis, and acute musculoskeletal injuries.

Quick summary

Diclofenac is an NSAID that alleviates pain and inflammation by blocking prostaglandin production.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy
BOXED WARNING

This medication carries a boxed (black box) warning — the strongest type of FDA warning. Review the full prescribing information before use.

Key facts at a glance

ATC
D11AX18
RxNorm
3355
Generic
Diclofenac
Class
atc-d11
Brands
Surpass Anti-Inflammatory, Flector, Zorvolex, Voltaren, Cataflam, Licart, Aleve Arthritis Pain, Lofena, Trifena, Xiclo, Arthrotec, Zipsor, Cambia, Pennsaid
Availability
otc
Pregnancy
C
Lactation
caution
Half-life (h)
2
Onset (min)
30
Duration (h)
6
Routes
oral, topical, ophthalmic, rectal
Forms
tablet, capsule, gel, solution, drops, suppository, patch, powder
Regions
United States, Canada, European Union, United Kingdom, Australia, Japan, India, worldwide
Monitoring
hepatic function, renal function, hematologic parameters, blood pressure, signs of GI bleeding

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
50mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
25mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
25mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose exceeding 10 grams may cause serious toxicity and potentially fatal outcomes
Chronic overdose: Prolonged use at high doses may lead to cumulative toxicity affecting liver and kidneys
Immediate actions
gastric lavage within 1 hour, activated charcoal, supportive care, monitoring of vital signs
Antidote
N-acetylcysteine(used for hepatoprotection, effectiveness highest when administered early)
Poison Control: 1-800-222-1222

Special Populations

10 groups
⚠

pregnancy

first trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks

Monitor

regular fetal monitoring

Use with caution and monitor for adverse effects.

✗

pregnancy

third trimester
contraindicated
FDA Category
D
Dose Adjustment

do not use

Key Recommendations

contraindicated in third trimester due to risk of premature closure of ductus arteriosus

Monitor

not applicable

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

lactation

breastfeeding
caution
FDA Category
N
Dose Adjustment

use lowest effective dose

Key Recommendations

small amounts pass into breast milk; generally considered compatible but use with caution

Monitor

monitor infant for adverse effects

Use with caution and monitor for adverse effects.

⚠

geriatric

elderly
caution
FDA Category
N
Dose Adjustment

start with lowest effective dose

Key Recommendations

increased risk of GI bleeding, renal impairment, and cardiovascular events; use with caution

Monitor

regular renal function and GI monitoring

Use with caution and monitor for adverse effects.

✗

pediatric_age

children under 2
contraindicated
FDA Category
N
Dose Adjustment

not recommended

Key Recommendations

not recommended for children under 2 years of age

Monitor

not applicable

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

pediatric_age

children 2 12
caution
FDA Category
N
Dose Adjustment

weight-based dosing required

Key Recommendations

use only under medical supervision; avoid in children with flu-like symptoms

Monitor

monitor for signs of GI bleeding and renal function

Use with caution and monitor for adverse effects.

✗

renal_impairment

severe
contraindicated
FDA Category
N
Dose Adjustment

do not use

Key Recommendations

contraindicated in severe renal impairment (CrCl <30 mL/min)

Monitor

not applicable

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

renal_impairment

mild moderate
caution
FDA Category
N
Dose Adjustment

reduce dose and monitor closely

Key Recommendations

use with caution in mild-moderate renal impairment; monitor renal function

Monitor

regular monitoring of serum creatinine and BUN

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

severe
caution
FDA Category
N
Dose Adjustment

use with extreme caution

Key Recommendations

use with extreme caution in severe hepatic impairment; avoid if possible

Monitor

regular liver function tests

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

mild moderate
caution
FDA Category
N
Dose Adjustment

may require dose reduction

Key Recommendations

use with caution; may require dose adjustment based on response

Monitor

monitor liver function tests periodically

Use with caution and monitor for adverse effects.

Statistics and clinical data

prescribingFDA
2023

FDA approval year

Value:1988

Original FDA approval year for Diclofenac

drug_classWHO
2023

Drug class

Value:NSAID (Non-Steroidal Anti-Inflammatory Drug)

Classification based on mechanism of action

mechanismFDA
2023

Mechanism of action

Value:COX-1 and COX-2 inhibitor

Primary pharmacological mechanism

usageMedical guidelines
2023

Common therapeutic uses

Value:Pain, inflammation, arthritis, migraine, dysmenorrhea

Approved therapeutic indications

Treats osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute musculoskeletal disorders, dysmenorrhea, dental pain, and mild-to-moderate postoperative pain.

Inhibits cyclooxygenase (COX) enzymes, reducing the synthesis of prostaglandins that cause pain, inflammation, and fever.

May cause gastrointestinal complications including ulcers and bleeding; carries cardiovascular and renal risks. Should be used at the lowest effective dose for the shortest duration. Contraindicated in late pregnancy and in patients with active peptic ulcer disease or severe kidney impairment.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy